Literature DB >> 9836510

Increased serum concentration of hyaluronate in dermatomyositis patients.

M Kubo1, K Kikuchi, N Yazawa, M Fujimoto, T Tamaki, K Tamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9836510     DOI： 10.1007/s004030050355

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  4 in total

Review 1.  Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal.

Authors:  Jonathan D Powell; Maureen R Horton
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 3.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

4.  Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions.

Authors:  Marilda Guimarães Silva; Samuel Katsuyuki Shinjo
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.